GlucoseZone

GlucoseZone Aims to Help Diabetic Patients Meet Exercise Needs for Safe and Effective Reduction and Control of Diabetes. GlucoseZone's patented proprietary program now has over 1 million users and is the world’s first digital workout solution specifically designed for people with diabetes, helping them improve their A1c levels and achieve weight loss based on real-time blood glucose levels. The company operates on a B2B business model. At GlucoseZone, we recognize that providers will prescribe reliable resources based on scientific evidence for their patients. In a 12-week clinical trial conducted by Yale New Haven Health, diabetic patients who were on the verge of escalating medication treatment switched to GlucoseZone. On average, their A1C levels decreased by 2.0%, and they lost an average of 9.4 pounds. These results were achieved through the introduction of GlucoseZone.